Cysteine cathepsins: Markers and therapy targets in lung disorders

Clinical Reviews in Bone and Mineral Metabolism

Volumn 9, Issue 2, 2011, Pages 148-161

  Kasabova, Mariana ^a   Saidi, Ahlame ^a   Naudin, Clément ^a   Sage, Juliette ^a,b   Lecaille, Fabien ^a   Lalmanach, Gilles ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b Parfums Christian Dior   (France)

Author keywords

Arthritis; Asthma; Bone disease; Cathepsin; Chronic obstructive pulmonary disease; Cysteine protease; Emphysema; Fibrosis; Osteoporosis; Protease inhibitor

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CATHEPSIN; CATHEPSIN B; CATHEPSIN F; CATHEPSIN H; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; CATHEPSIN V; CATHEPSIN X; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; TETRASPANIN; WNT PROTEIN;

ANTIGEN PRESENTATION; ASTHMA; BONE METASTASIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EMPHYSEMA; EXTRACELLULAR MATRIX; HUMAN; LUNG ALVEOLUS PROTEINOSIS; LUNG CANCER; LUNG DISEASE; LUNG DYSPLASIA; LYMPHANGIOLEIOMYOMATOSIS; NONHUMAN; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS; PATHOGENESIS; PNEUMONIA; REVIEW; RHEUMATOID ARTHRITIS; SILICOSIS;

EID: 79960072550     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9094-6     Document Type: Review

References (182)

1. ND Rawlings AJ Barrett A Bateman 2010 MEROPS: the peptidase database Nucleic Acids Res 38 Database issue D227 D233 19892822 1:CAS:528: DC%2BC3cXktlyltQ%3D%3D
2. K Brix A Dunkhorst K Mayer S Jordans 2008 Cysteine cathepsins: cellular roadmap to different functions Biochimie 90 2 194 207 17825974 1:CAS:528:DC%2BD1cXhsVGkt7c%3D (Pubitemid 351172569)
3. PJ Wolters HA Chapman 2000 Importance of lysosomal cysteine proteases in lung disease Respir Res 1 3 170 177 11667982 1:CAS:528:DC%2BD3MXosVaru74%3D
4. B Goulet A Baruch N-S Moon M Poirier LL Sansregret A Erickson, et al. 2004 A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor Mol Cell 14 2 207 219 15099520 1:CAS:528:DC%2BD2cXjvVyisb0%3D (Pubitemid 38515648)
5. B Turk D Turk V Turk 2000 Lysosomal cysteine proteases: more than scavengers Biochim Biophys Acta 1477 1-2 98 111 10708852 1:CAS:528: DC%2BD3cXhsFGktLo%3D (Pubitemid 30119895)
6. F Lecaille J Kaleta D Brömme 2002 Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design Chem Rev 102 12 4459 4488 12475197 1:CAS:528:DC%2BD38XovVChtb0%3D
7. B Wiederanders 2003 Structure-function relationships in class CA1 cysteine peptidase propeptides Acta Biochim Pol 50 3 691 713 14515150 1:CAS:528:DC%2BD3sXps12qsLw%3D (Pubitemid 38623802)
8. F Lecaille D Brömme G Lalmanach 2008 Biochemical properties and regulation of cathepsin K activity Biochimie 90 2 208 226 17935853 1:CAS:528:DC%2BD1cXhsVGktL4%3D (Pubitemid 351200459)
9. W Bode R Engh D Musil B Laber M Stubbs R Huber, et al. 1990 Mechanism of interaction of cysteine proteinases and their protein inhibitors as compared to the serine proteinase-inhibitor interaction Biol Chem Hoppe-Seyler 371 Suppl 111 118 2205234 1:CAS:528:DyaK3cXmt1Kru74%3D (Pubitemid 20331090)
10. B Turk D Turk GS Salvesen 2002 Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators Curr Pharm Des 8 18 1623 1637 12132995 1:CAS:528:DC%2BD38XltlCqtLc%3D (Pubitemid 34752830)
11. Abrahamson M, Alvarez-Fernandez M, Nathanson C-M. Cystatins. Biochem. Soc. Symp. 2003;(70):179-99.
12. V Turk V Stoka D Turk 2008 Cystatins: biochemical and structural properties, and medical relevance Front Biosci 13 5406 5420 18508595 1:CAS:528:DC%2BD1cXnsVOjur8%3D
13. EM Duncan TL Muratore-Schroeder RG Cook BA Garcia J Shabanowitz DF Hunt, et al. 2008 Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation Cell 135 2 284 294 18957203 1:CAS:528:DC%2BD1cXhtlWhsrzO
14. V Hook L Funkelstein D Lu S Bark J Wegrzyn S-R Hwang 2008 Proteases for processing proneuropeptides into peptide neurotransmitters and hormones Annu Rev Pharmacol Toxicol 48 393 423 18184105 1:CAS:528:DC%2BD1cXisFynu7c%3D (Pubitemid 351738159)
15. W Roth J Deussing VA Botchkarev M Pauly-Evers P Saftig A Hafner, et al. 2000 Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling FASEB J 14 13 2075 2086 11023992 1:CAS:528:DC%2BD3MXhtF2rtL4%3D
16. B Friedrichs C Tepel T Reinheckel J Deussing K von Figura V Herzog, et al. 2003 Thyroid functions of mouse cathepsins B, K, and L J Clin Invest 111 11 1733 1745 12782676 1:CAS:528:DC%2BD3sXksVKrsLk%3D (Pubitemid 38057754)
17. K Honey AY Rudensky 2003 Lysosomal cysteine proteases regulate antigen presentation Nat Rev Immunol 3 6 472 482 12776207 1:CAS:528:DC%2BD3sXktFOhtbo%3D (Pubitemid 37339187)
18. B Turk V Turk 2009 Lysosomes as « suicide bags » in cell death: myth or reality? J Biol Chem 284 33 21783 21787 19473965 1:CAS:528:DC%2BD1MXpsFymsb0%3D
19. HA Chapman RJ Riese GP Shi 1997 Emerging roles for cysteine proteases in human biology Annu Rev Physiol 59 63 88 9074757 1:CAS:528:DyaK2sXhvVSjt7g%3D (Pubitemid 27142435)
20. V Turk B Turk D Turk 2001 Lysosomal cysteine proteases: facts and opportunities EMBO J 20 17 4629 4633 11532926 1:CAS:528:DC%2BD3MXnt1CmtrY%3D (Pubitemid 32848615)
21. MM Mohamed BF Sloane 2006 Cysteine cathepsins: multifunctional enzymes in cancer Nat Rev Cancer 6 10 764 775 16990854 1:CAS:528:DC%2BD28XpvVCmu7Y%3D (Pubitemid 44450465)
22. J-C Lafarge N Naour K Clément M Guerre-Millo 2010 Cathepsins and cystatin C in atherosclerosis and obesity Biochimie 92 11 1580 1586 20417681 1:CAS:528:DC%2BC3cXhtl2isLvP
23. J Reiser B Adair T Reinheckel 2010 Specialized roles for cysteine cathepsins in health and disease J Clin Invest 120 10 3421 3431 20921628 1:CAS:528:DC%2BC3cXht1GgtLnL
24. B Turk 2006 Targeting proteases: successes, failures and future prospects Nat Rev Drug Discov 5 9 785 799 16955069 1:CAS:528:DC%2BD28XptVCltrs%3D (Pubitemid 44323703)
25. O Vasiljeva T Reinheckel C Peters D Turk V Turk B Turk 2007 Emerging roles of cysteine cathepsins in disease and their potential as drug targets Curr Pharm Des 13 4 387 403 17311556 1:CAS:528:DC%2BD2sXjvVyltrg%3D (Pubitemid 46477760)
26. M Drag GS Salvesen 2010 Emerging principles in protease-based drug discovery Nat Rev Drug Discov 9 9 690 701 20811381 1:CAS:528:DC%2BC3cXhtFSisbzP
27. Y Yasuda J Kaleta D Brömme 2005 The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics Adv Drug Deliv Rev 57 7 973 993 15876399 1:CAS:528:DC%2BD2MXjvVKmsr8%3D (Pubitemid 40703885)
28. DS Yamashita RW Marquis R Xie SD Nidamarthy H-J Oh JU Jeong, et al. 2006 Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors J Med Chem 49 5 1597 1612 16509577 1:CAS:528:DC%2BD28XhtlOrs78%3D (Pubitemid 43376505)
29. AL Boskey BD Gelb E Pourmand V Kudrashov SB Doty L Spevak, et al. 2009 Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates Calcif Tissue Int 84 3 229 239 19172215 1:CAS:528:DC%2BD1MXivVWksL8%3D
30. TY Nakagawa WH Brissette PD Lira RJ Griffiths N Petrushova J Stock, et al. 1999 Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice Immunity 10 2 207 217 10072073 1:CAS:528:DyaK1MXhs1yms78%3D (Pubitemid 29115626)
31. JJM Wiener S Sun RL Thurmond 2010 Recent advances in the design of cathepsin S inhibitors Curr Top Med Chem 10 7 717 732 20337580 1:CAS:528:DC%2BC3cXmsF2ktr4%3D
32. HA Chapman GP Shi 2000 Protease injury in the development of COPD: Thomas A Neff Lecture Chest 117 5 Suppl 1 295S 299S 1:CAS:528:DC%2BD3cXjvFShu7Y%3D
33. SD Shapiro 2002 Proteinases in chronic obstructive pulmonary disease Biochem Soc Trans 30 2 98 102 12023833 1:CAS:528:DC%2BD38XjvVKhtL4%3D
34. F Bühling C Röcken F Brasch R Hartig Y Yasuda P Saftig, et al. 2004 Pivotal role of cathepsin K in lung fibrosis Am J Pathol 164 6 2203 2216 15161653 (Pubitemid 38669366)
35. G Lalmanach E Diot E Godat F Lecaille V Hervé-Grépinet 2006 Cysteine cathepsins and caspases in silicosis Biol Chem 387 7 863 870 16913835 1:CAS:528:DC%2BD28XnvFanu78%3D (Pubitemid 44100232)
36. F Veillard F Lecaille G Lalmanach 2008 Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system? Int J Biochem Cell Biol 40 6-7 1079 1094 18093865 1:CAS:528:DC%2BD1cXlslGltbo%3D
37. F Bühling A Gerber C Häckel S Krüger T Köhnlein D Brömme, et al. 1999 Expression of cathepsin K in lung epithelial cells Am J Respir Cell Mol Biol 20 4 612 619 10100992 (Pubitemid 129495649)
38. HA Chapman JS Munger GP Shi 1994 The role of thiol proteases in tissue injury and remodeling Am J Respir Crit Care Med 150 6 Pt 2 S155 S159 7952652
39. F Bühling N Waldburg A Reisenauer A Heimburg H Golpon T Welte 2004 Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Eur Respir J 23 4 620 628 15083765 (Pubitemid 38456008)
40. O Altiok R Yasumatsu G Bingol-Karakoc RJ Riese MT Stahlman W Dwyer, et al. 2006 Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia Am J Respir Crit Care Med 173 3 318 326 16166622 1:CAS:528:DC%2BD28XmslSks70%3D (Pubitemid 43209087)
41. C Haeckel S Krueger F Buehling D Broemme K Franke A Schuetze, et al. 1999 Expression of cathepsin K in the human embryo and fetus Dev Dyn 216 2 89 95 10536050 1:STN:280:DC%2BD3c%2Fgs1Chsg%3D%3D (Pubitemid 29471173)
42. JM Davidson 1990 Biochemistry and turnover of lung interstitium Eur Respir J 3 9 1048 1063 2289553 1:CAS:528:DyaK3MXit1KhsL0%3D
43. A Punturieri S Filippov E Allen I Caras R Murray V Reddy, et al. 2000 Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages J Exp Med 192 6 789 799 10993910 1:CAS:528:DC%2BD3cXmslGmt7c%3D
44. P Garnero O Borel I Byrjalsen M Ferreras FH Drake MS McQueney, et al. 1998 The collagenolytic activity of cathepsin K is unique among mammalian proteinases J Biol Chem 273 48 32347 32352 9822715 1:CAS:528:DyaK1cXnvVelu7c%3D (Pubitemid 29177183)
45. W Kafienah D Brömme DJ Buttle LJ Croucher AP Hollander 1998 Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix Biochem J 331 Pt 3 727 732 9560298 1:CAS:528:DyaK1cXjt12iu7s%3D (Pubitemid 28211893)
46. Y Yasuda Z Li D Greenbaum M Bogyo E Weber D Brömme 2004 Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages J. Biol. Chem 279 35 36761 36770 15192101 1:CAS:528:DC%2BD2cXmvFCmsb4%3D (Pubitemid 39129024)
47. M Novinec RN Grass WJ Stark V Turk A Baici B Lenarcic 2007 Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors J Biol Chem 282 11 7893 7902 17227755 1:CAS:528:DC%2BD2sXis1Kgsbg%3D (Pubitemid 47093571)
48. P Bryant H Ploegh 2004 Class II MHC peptide loading by the professionals Curr Opin Immunol 16 1 96 102 14734116 1:CAS:528:DC%2BD2cXltFaitA%3D%3D (Pubitemid 38198123)
49. LC Hsing AY Rudensky 2005 The lysosomal cysteine proteases in MHC class II antigen presentation Immunol Rev 207 229 241 16181340 1:CAS:528: DC%2BD2MXhtFOqtL%2FJ (Pubitemid 41415021)
50. T Zavasnik-Bergant B Turk 2006 Cysteine cathepsins in the immune response Tissue Antigens 67 5 349 355 16671941 1:CAS:528:DC%2BD28XmtVOmtL8%3D
51. J Bania E Gatti H Lelouard A David F Cappello E Weber, et al. 2003 Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs Proc Natl Acad Sci USA 100 11 6664 6669 12748383 1:CAS:528:DC%2BD3sXktlygs7s%3D (Pubitemid 36666638)
52. E Tolosa W Li Y Yasuda W Wienhold LK Denzin A Lautwein, et al. 2003 Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis J Clin Invest 112 4 517 526 12925692 1:CAS:528:DC%2BD3sXms1Wntbk%3D (Pubitemid 38056336)
53. T Nakagawa W Roth P Wong A Nelson A Farr J Deussing, et al. 1998 Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus Science 280 5362 450 453 9545226 1:CAS:528:DyaK1cXivVeku7c%3D (Pubitemid 28208170)
54. K Honey T Nakagawa C Peters A Rudensky 2002 Cathepsin L regulates CD4 + T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands J Exp Med 195 10 1349 1358 12021314 1:CAS:528:DC%2BD38XjvFegtLo%3D (Pubitemid 34564336)
55. RJ Riese RN Mitchell JA Villadangos GP Shi JT Palmer ER Karp, et al. 1998 Cathepsin S activity regulates antigen presentation and immunity J Clin Invest 101 11 2351 2363 9616206 1:CAS:528:DyaK1cXjvVWrtLs%3D (Pubitemid 28270429)
56. GP Shi RA Bryant R Riese S Verhelst C Driessen Z Li, et al. 2000 Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages J Exp Med 191 7 1177 1186 10748235 1:CAS:528:DC%2BD3cXit1ygurg%3D
57. I Garcia-Verdugo D Descamps M Chignard L Touqui J-M Sallenave 2010 Lung protease/anti-protease network and modulation of mucus production and surfactant activity Biochimie 92 11 1608 1617 20493919 1:CAS:528:DC%2BC3cXhtl2isLvK
58. G Devendra RG Spragg 2002 Lung surfactant in subacute pulmonary disease Respir Res 3 19 11980588
59. E Crouch JR Wright 2001 Surfactant proteins a and d and pulmonary host defense Annu Rev Physiol 63 521 554 11181966 1:CAS:528:DC%2BD3MXjtFKmtbo%3D (Pubitemid 32304328)
60. M Griese 1999 Pulmonary surfactant in health and human lung diseases: state of the art Eur Respir J 13 6 1455 1476 10445627 1:CAS:528: DyaK1MXlsFGrur0%3D (Pubitemid 29357168)
61. JR Wright 2005 Immunoregulatory functions of surfactant proteins Nat Rev Immunol 5 1 58 68 15630429 1:CAS:528:DC%2BD2MXlvVOm (Pubitemid 40070331)
62. Y Ito RJ Mason 2010 The effect of interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of surfactant proteins in adult human alveolar type II cells in vitro Respir Res 11 157 21067601
63. C Von Bredow A Wiesener M Griese 2003 Proteolysis of surfactant protein D by cystic fibrosis relevant proteases Lung 181 2 79 88 (Pubitemid 37026548)
64. TO Hirche EC Crouch M Espinola TJ Brokelman RP Mecham N DeSilva, et al. 2004 Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain J Biol Chem 279 26 27688 27698 15078883 1:CAS:528:DC%2BD2cXkvFGnurk%3D (Pubitemid 38812610)
65. S Guttentag L Robinson P Zhang F Brasch F Bühling M Beers 2003 Cysteine protease activity is required for surfactant protein B processing and lamellar body genesis Am J Respir Cell Mol Biol 28 1 69 79 12495934 1:CAS:528:DC%2BD3sXhvVajug%3D%3D (Pubitemid 36017052)
66. F Brasch A Ten Brinke G Johnen M Ochs N Kapp KM Müller, et al. 2002 Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes Am J Respir Cell Mol Biol 26 6 659 670 12034564 1:CAS:528:DC%2BD38XkslWqsr0%3D (Pubitemid 34557366)
67. F Brasch M Ochs T Kahne S Guttentag V Schauer-Vukasinovic M Derrick, et al. 2003 Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung J Biol Chem 278 49 49006 49014 13129928 1:CAS:528:DC%2BD3sXptlGrsrw%3D
68. T Ueno S Linder C-L Na WR Rice J Johansson TE Weaver 2004 Processing of pulmonary surfactant protein B by napsin and cathepsin H J Biol Chem 279 16 16178 16184 14766755 1:CAS:528:DC%2BD2cXivF2qsLc%3D (Pubitemid 38509310)
69. C Palermo JA Joyce 2008 Cysteine cathepsin proteases as pharmacological targets in cancer Trends Pharmacol Sci 29 1 22 28 18037508 1:CAS:528: DC%2BD1cXis1eiug%3D%3D
70. C López-Otín LM Matrisian 2007 Emerging roles of proteases in tumour suppression Nat Rev Cancer 7 10 800 808 17851543 (Pubitemid 47463671)
71. B Ulbricht H Henny H Horstmann H Spring W Faigle E Spiess 1997 Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the localization of cathepsin B and cathepsin L in human lung tumor cells Eur J Cell Biol 74 3 294 301 9402478 1:CAS:528:DyaK2sXntlSisLc%3D (Pubitemid 27490221)
72. J Mai RL Finley DM Waisman BF Sloane 2000 Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells J Biol Chem 275 17 12806 12812 10777578 1:CAS:528:DC%2BD3cXjtVarur0%3D (Pubitemid 30241435)
73. D Cavallo-Medved J Mai J Dosescu M Sameni BF Sloane 2005 Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells J Cell Sci 118 Pt 7 1493 1503 15769846 1:CAS:528: DC%2BD2MXjslGktrY%3D (Pubitemid 40585129)
74. LYW Bourguignon PA Singleton F Diedrich R Stern E Gilad 2004 CD44 interaction with Na + -H + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion J Biol Chem 279 26 26991 27007 15090545 1:CAS:528:DC%2BD2cXkvFGnsrY%3D (Pubitemid 38812535)
75. I Giusti S D'Ascenzo D Millimaggi G Taraboletti G Carta N Franceschini, et al. 2008 Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles Neoplasia 10 5 481 488 18472965 1:CAS:528: DC%2BD1cXoslWgtLo%3D (Pubitemid 351657390)
76. L Gillet S Roger P Besson F Lecaille J Gore P Bougnoux, et al. 2009 Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells J Biol Chem 284 13 8680 8691 19176528 1:CAS:528:DC%2BD1MXjsVSit7Y%3D
77. J Grimm DG Kirsch SD Windsor CFB Kim PM Santiago V Ntziachristos, et al. 2005 Use of gene expression profiling to direct in vivo molecular imaging of lung cancer Proc Natl Acad Sci USA 102 40 14404 14409 16183744 1:CAS:528:DC%2BD2MXhtFCgsr%2FE (Pubitemid 41429710)
78. V Gocheva W Zeng D Ke D Klimstra T Reinheckel C Peters, et al. 2006 Distinct roles for cysteine cathepsin genes in multistage tumorigenesis Genes Dev 20 5 543 556 16481467 1:CAS:528:DC%2BD28Xit1Kmtbw%3D (Pubitemid 43345321)
79. C Kopitz M Anton B Gansbacher A Krüger 2005 Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host Cancer Res 65 19 8608 8612 16204025 1:CAS:528:DC%2BD2MXhtVKiurfK (Pubitemid 41377344)
80. J Zhang R Shridhar Q Dai J Song SC Barlow L Yin, et al. 2004 Cystatin m: a novel candidate tumor suppressor gene for breast cancer Cancer Res 64 19 6957 6964 15466187 1:CAS:528:DC%2BD2cXotFals7Y%3D (Pubitemid 39331005)
81. D Keppler 2006 Towards novel anti-cancer strategies based on cystatin function Cancer Lett 235 2 159 176 15893421 1:CAS:528:DC%2BD28Xjs1ahs70%3D
82. W Li F Ding L Zhang Z Liu Y Wu A Luo, et al. 2005 Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis Clin Cancer Res 11 24 Pt 1 8753 8762 16361563 1:CAS:528:DC%2BD2MXhtlWrsbvL (Pubitemid 43005926)
83. RE Burden JA Gormley TJ Jaquin DM Small DJ Quinn SM Hegarty, et al. 2009 Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis Clin Cancer Res 15 19 6042 6051 19789302 1:CAS:528: DC%2BD1MXhtF2lur7M
84. Ward C, Kuehn D, Burden RE, Gormley JA, Jaquin TJ, Gazdoiu M, et al. Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS ONE. 2010;5(9).
85. D Jean M Bar-Eli S Huang K Xie F Rodrigues-Lima J Hermann, et al. 1996 A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma Cancer Res 56 2 254 258 8542576 1:CAS:528:DyaK28XmtVGguw%3D%3D (Pubitemid 26026350)
86. T Reinheckel S Hagemann S Dollwet-Mack E Martinez T Lohmüller G Zlatkovic, et al. 2005 The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling J Cell Sci 118 Pt 15 3387 3395 16079282 1:CAS:528:DC%2BD2MXpvFKmt70%3D (Pubitemid 41246094)
87. J Dennemärker T Lohmüller J Mayerle M Tacke MM Lerch LM Coussens, et al. 2010 Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis Oncogene 29 11 1611 1621 20023699
88. MJ Duffy 1996 Proteases as prognostic markers in cancer Clin Cancer Res 2 4 613 618 9816210 1:CAS:528:DyaK28Xis1Wltb4%3D (Pubitemid 26133464)
89. J Kos B Werle T Lah N Brunner 2000 Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer Int J Biol Markers 15 1 84 89 10763147 1:CAS:528:DC%2BD3cXivF2nurs%3D (Pubitemid 30195490)
90. L Herszényi F Farinati R Cardin G István LD Molnár I Hritz, et al. 2008 Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer BMC Cancer 8 194 18616803
91. J Kos TT Lah 1998 Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review) Oncol Rep 5 6 1349 1361 9769367 1:CAS:528:DyaK1cXntFSrtrY%3D (Pubitemid 28474074)
92. TT Lah M Kokalj-Kunovar M Drobnic-Kosorok J Babnik R Golouh I Vrhovec, et al. 1992 Cystatins and cathepsins in breast carcinoma Biol Chem Hoppe-Seyler 373 7 595 604 1515089 1:STN:280:DyaK38zosV2ksg%3D%3D
93. B Werle U Schanzenbächer TT Lah E Ebert B Jülke W Ebert, et al. 2006 Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis Oncol Rep 16 4 647 655 16969475 1:CAS:528: DC%2BD28XhtFSisr%2FF
94. KD Bhoola CD Figueroa K Worthy 1992 Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol Rev 44 1 1 80 1313585 1:CAS:528: DyaK38XktVSqtLw%3D
95. C Desmazes L Galineau F Gauthier D Brömme G Lalmanach 2003 Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L Eur J Biochem 270 1 171 178 12492488 1:CAS:528:DC%2BD3sXktFKisg%3D%3D (Pubitemid 36056947)
96. C Naudin F Lecaille S Chowdhury JC Krupa E Purisima JS Mort, et al. 2010 The occluding loop of cathepsin B prevents its effective inhibition by human kininogens J Mol Biol 400 5 1022 1035 20538006 1:CAS:528:DC%2BC3cXovFygtrg%3D
97. C Desmazes F Gauthier G Lalmanach 2001 Cathepsin L, but not cathepsin B, is a potential kininogenase Biol Chem 382 5 811 815 11517935 1:CAS:528:DC%2BD3MXlvFSksbc%3D (Pubitemid 32631719)
98. L Puzer J Vercesi MFM Alves NMT Barros MS Araujo M Aparecida Juliano, et al. 2005 A possible alternative mechanism of kinin generation in vivo by cathepsin L Biol Chem 386 7 699 704 16207091 1:CAS:528:DC%2BD2MXntVaru7k%3D (Pubitemid 41448172)
99. E Godat F Lecaille C Desmazes S Duchêne E Weidauer P Saftig, et al. 2004 Cathepsin K: a cysteine protease with unique kinin-degrading properties Biochem J 383 Pt. 3 501 506 15265002 1:CAS:528:DC%2BD2cXovVOht78%3D (Pubitemid 39546120)
100. F Lecaille C Vandier E Godat V Hervé-Grépinet D Brömme G Lalmanach 2007 Modulation of hypotensive effects of kinins by cathepsin K Arch Biochem Biophys 459 1 129 136 17181996 1:CAS:528:DC%2BD2sXitFOktL4%3D (Pubitemid 46282593)
101. H Heitsch 2000 Bradykinin B2 receptor as a potential therapeutic target Drug News Perspect 13 4 213 225 12937626 1:CAS:528:DC%2BD3cXms1Ohuro%3D
102. K Ohashi M Naruto T Nakaki E Sano 2003 Identification of interleukin-8 converting enzyme as cathepsin L Biochim Biophys Acta 1649 1 30 39 12818188 1:CAS:528:DC%2BD3sXksF2htL0%3D (Pubitemid 38234592)
103. A Wille A Heimburg A Gerber A Reisenauer T Welte F Bühling 2002 Functional consequences of cathepsin L deficiency in human lung epithelial cells Biol Chem 383 7-8 1291 1296 12437119 1:CAS:528:DC%2BD38Xptl2iu78%3D (Pubitemid 35215080)
104. F Bühling A Reisenauer A Gerber S Krüger E Weber D Brömme, et al. 2001 Cathepsin K-a marker of macrophage differentiation? J Pathol 195 3 375 382 11673837
105. EJD Oudijk JWJ Lammers L Koenderman 2003 Systemic inflammation in chronic obstructive pulmonary disease Eur Respir J Suppl 46 5s 13s 14621102 1:STN:280:DC%2BD3srjvFOgtA%3D%3D (Pubitemid 37351732)
106. Owen CA. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):373-85 (discussion 394-95). (Pubitemid 41699700)
107. PJ Barnes SD Shapiro RA Pauwels 2003 Chronic obstructive pulmonary disease: molecular and cellular mechanisms Eur Respir J 22 4 672 688 14582923 1:CAS:528:DC%2BD3sXovFGgtLY%3D (Pubitemid 37258549)
108. K Takeyabu T Betsuyaku M Nishimura A Yoshioka M Tanino K Miyamoto, et al. 1998 Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema Eur Respir J 12 5 1033 1039 9863993 1:STN:280:DyaK1M%2FnvFKqtQ%3D%3D (Pubitemid 28545608)
109. P Golovatch BA Mercer V Lemaître A Wallace RF Foronjy J D'Armiento 2009 Role for cathepsin K in emphysema in smoke-exposed guinea pigs Exp Lung Res 35 8 631 645 19895319 1:CAS:528:DC%2BD1MXhsVyis7vM
110. M-J Kang RJ Homer A Gallo CG Lee KA Crothers SJ Cho, et al. 2007 IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation J Immunol 178 3 1948 1959 17237446 1:CAS:528:DC%2BD2sXntVGrtg%3D%3D (Pubitemid 46154668)
111. P Puddu L Fantuzzi P Borghi B Varano G Rainaldi E Guillemard, et al. 1997 IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages J Immunol 159 7 3490 3497 9317148 1:CAS:528:DyaK2sXmtlOntLw%3D (Pubitemid 127482108)
112. T Zheng Z Zhu Z Wang RJ Homer B Ma RJ Riese, et al. 2000 Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema J Clin Invest 106 9 1081 1093 11067861 1:CAS:528:DC%2BD3cXnvFyqtbg%3D
113. T Zheng MJ Kang K Crothers Z Zhu W Liu CG Lee, et al. 2005 Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema J Immunol 174 12 8106 8115 15944319 1:CAS:528:DC%2BD2MXkvVOlsL8%3D (Pubitemid 40806322)
114. AS Williams PR Eynott S-Y Leung P Nath R Jupp GT De Sanctis, et al. 2009 Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation Pulm Pharmacol Ther 22 1 27 32 19041950 1:CAS:528:DC%2BD1MXhtVCrurw%3D
115. FY Jin C Nathan D Radzioch A Ding 1997 Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide Cell 88 3 417 426 9039268 1:CAS:528:DyaK2sXhtFagurY%3D (Pubitemid 27131383)
116. P Geraghty CM Greene M O'Mahony SJ O'Neill CC Taggart NG McElvaney 2007 Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression J Biol Chem 282 46 33389 33395 17878156 1:CAS:528:DC%2BD2sXht1Oru7fJ (Pubitemid 350159551)
117. CC Taggart GJ Lowe CM Greene AT Mulgrew SJ O'Neill RL Levine, et al. 2001 Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor J Biol Chem 276 36 33345 33352 11435427 1:CAS:528:DC%2BD3MXmslymurY%3D
118. X Zhang P Shan G Jiang L Cohn PJ Lee 2006 Toll-like receptor 4 deficiency causes pulmonary emphysema J Clin Invest 116 11 3050 3059 17053835 1:CAS:528:DC%2BD28XhtFyrsb7O (Pubitemid 44684490)
119. MH Hannothiaux A Scharfman A Wastiaux L Cornu E van Brussel JJ Lafitte, et al. 1991 An attempt to evaluate lung aggression in monkey silicosis: hydrolases, peroxidase and antiproteases activities in serial bronchoalveolar lavages Eur Respir J 4 2 191 204 1646117 1:CAS:528:DyaK3MXlt12gu7c%3D
120. RJ Langley R Kalra NC Mishra FF Hahn S Razani-Boroujerdi SP Singh, et al. 2004 A biphasic response to silica: I Immunostimulation is restricted to the early stage of silicosis in lewis rats Am J Respir Cell Mol Biol 30 6 823 829 14742293 1:CAS:528:DC%2BD2cXkvVyjsLg%3D (Pubitemid 38736906)
121. JD Brain 1986 Toxicological aspects of alterations of pulmonary macrophage function Annu Rev Pharmacol Toxicol 26 547 565 3521463 1:STN:280:DyaL283ktVOntA%3D%3D (Pubitemid 16090972)
122. J Pérez-Ramos M de Lourdes Segura-Valdez B Vanda M Selman A Pardo 1999 Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis Am J Respir Crit Care Med 160 4 1274 1282 10508819 (Pubitemid 29487471)
123. JF Scabilloni L Wang JM Antonini JR Roberts V Castranova RR Mercer 2005 Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation Am J Physiol Lung Cell Mol Physiol 288 4 L709 L717 15608151 1:CAS:528:DC%2BD2MXjtlyjtLk%3D
124. S Van den Brûle P Misson F Bühling D Lison F Huaux 2005 Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta Respir Res 6 84 16045809
125. C Perdereau E Godat M-C Maurel E Hazouard E Diot G Lalmanach 2006 Cysteine cathepsins in human silicotic bronchoalveolar lavage fluids Biochim Biophys Acta 1762 3 351 356 16303289 1:CAS:528:DC%2BD28XhtFWitLg%3D (Pubitemid 43172851)
126. DJ Quinn S Weldon CC Taggart 2010 Antiproteases as therapeutics to target inflammation in cystic fibrosis Open Respir Med J 4 20 31 20448835 1:CAS:528:DC%2BC3cXkvFynt78%3D
127. SL Martin KL Moffitt A McDowell C Greenan RJ Bright-Thomas AM Jones, et al. 2010 Association of airway cathepsin B and S with inflammation in cystic fibrosis Pediatr Pulmonol 45 9 860 868 20632407 1:STN:280:DC%2BC3cjotVCluw%3D%3D
128. S Tate G MacGregor M Davis JA Innes AP Greening 2002 Airways in cystic fibrosis are acidified: detection by exhaled breath condensate Thorax 57 11 926 929 12403872 1:STN:280:DC%2BD38nksFegsg%3D%3D (Pubitemid 35316268)
129. CC Taggart CM Greene SG Smith RL Levine PB McCray S O'Neill, et al. 2003 Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins J Immunol 171 2 931 937 12847264 1:CAS:528:DC%2BD3sXltFymu7s%3D (Pubitemid 36871407)
130. MP Rogan CC Taggart CM Greene PG Murphy SJ O'Neill NG McElvaney 2004 Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis J Infect Dis 190 7 1245 1253 15346334 1:CAS:528:DC%2BD2cXovVWnu7w%3D (Pubitemid 39287750)
131. CC Taggart S-A Cryan S Weldon A Gibbons CM Greene E Kelly, et al. 2005 Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding J Exp Med 202 12 1659 1668 16352738 1:CAS:528:DC%2BD2MXhtlCjsrjP (Pubitemid 41815872)
132. DA Johnson AJ Barrett RW Mason 1986 Cathepsin L inactivates alpha 1-proteinase inhibitor by cleavage in the reactive site region J Biol Chem 261 31 14748 14751 3490478 1:CAS:528:DyaL28Xmt1Wmu7Y%3D (Pubitemid 17220272)
133. AM Gibbons NG McElvaney CC Taggart S-A Cryan 2009 Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation J Microencapsul 26 6 513 522 18925490 1:CAS:528:DC%2BD1MXhtValsrbI
134. CD Wright AM Havill SC Middleton MA Kashem PA Lee DJ Dripps, et al. 1999 Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma J Pharmacol Exp Ther 289 2 1007 1014 10215681 1:CAS:528:DyaK1MXislGisL8%3D (Pubitemid 29191260)
135. RM Forteza A Ahmed T Lee WM Abraham 2001 Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction Pulm Pharmacol Ther 14 2 107 110 11273791 1:CAS:528:DC%2BD3MXitFyltb4%3D (Pubitemid 32553614)
136. NG McElvaney H Nakamura P Birrer CA Hébert WL Wong M Alphonso, et al. 1992 Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor J Clin Invest 90 4 1296 1301 1357002 1:STN:280:DyaK3s%2Fhs1ymuw%3D%3D
137. A Gibbons NG McElvaney S-A Cryan 2010 A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation AAPS PharmSciTech 11 3 1411 1421 20839079 1:CAS:528:DC%2BC3cXhsFemsbzL
138. P Geraghty MP Rogan CM Greene ML Brantly SJ O'Neill CC Taggart, et al. 2008 Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro Thorax 63 7 621 626 18250185 1:STN:280:DC%2BD1cvhvFyksw%3D%3D (Pubitemid 351969256)
139. JJ Coalson 2003 Pathology of new bronchopulmonary dysplasia Semin Neonatol 8 1 73 81 12667832 (Pubitemid 36356495)
140. TA Merritt CG Cochrane K Holcomb B Bohl M Hallman D Strayer, et al. 1983 Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia J Clin Invest 72 2 656 666 6603478 1:CAS:528:DyaL3sXltVeisL4%3D (Pubitemid 13051327)
141. MC Bruce M Schuyler RJ Martin BC Starcher JF Tomashefski KE Wedig 1992 Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia Am Rev Respir Dis 146 1 204 212 1626805 1:STN:280:DyaK38zivVegtA%3D%3D
142. J Knaapi H Lukkarinen R Kiviranta A Steiner P Lassus S Andersson, et al. 2006 Cathepsin K expression is diminished in infants with bronchopulmonary dysplasia Acta Paediatr 95 10 1298 1300 16982505 (Pubitemid 44423198)
143. H Hirakawa RA Pierce G Bingol-Karakoc C Karaaslan M Weng G-P Shi, et al. 2007 Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury Am J Respir Crit Care Med 176 8 778 785 17673697 1:CAS:528:DC%2BD2sXhtleru77L (Pubitemid 47598479)
144. M Srivastava S Jung J Wilhelm L Fink F Bühling T Welte, et al. 2005 The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles J Immunol 175 3 1884 1893 16034132 1:CAS:528: DC%2BD2MXmtlWju7g%3D (Pubitemid 41023095)
145. GT Layton SJ Harris FA Bland SR Lee S Fearn J Kaleta, et al. 2001 Therapeutic effects of cysteine protease inhibition in allergic lung inflammation: inhibition of allergen-specific T lymphocyte migration Inflamm Res 50 8 400 408 11556520 1:CAS:528:DC%2BD3MXnsFCrsrs%3D (Pubitemid 32777666)
146. I Fajardo L Svensson A Bucht G Pejler 2004 Increased levels of hypoxia-sensitive proteins in allergic airway inflammation Am J Respir Crit Care Med 170 5 477 484 15151919 (Pubitemid 39209127)
147. N Cimerman PM Brguljan M Krasovec S Suskovic J Kos 2001 Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients Pflugers Arch 442 61 R204 R206 11678341 1:CAS:528:DC%2BD3MXos1Wqsb4%3D
148. H Korideck JD Peterson 2009 Noninvasive quantitative tomography of the therapeutic response to dexamethasone in ovalbumin-induced murine asthma J Pharmacol Exp Ther 329 3 882 889 19293392 1:CAS:528:DC%2BD1MXms1ehtbY%3D
149. Deschamps K, Cromlish W, Weicker S, Lamontagne S, Huszar SL, Gauthier JY, et al. Genetic and pharmacological evaluation of cathepsin S in a mouse model of asthma. Am J Respir Cell Mol Biol. (DOI information: doi: 10.1165/rcmb.2009-0392OC ) (in press).
150. JR Somoza JT Palmer JD Ho 2002 The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators J Mol Biol 322 3 559 568 12225749 1:CAS:528:DC%2BD38Xmslalsrc%3D
151. M Chilosi M Pea G Martignoni M Brunelli S Gobbo V Poletti, et al. 2009 Cathepsin-k expression in pulmonary lymphangioleiomyomatosis Mod Pathol 22 2 161 166 19060845 1:CAS:528:DC%2BD1MXhtFOlsr0%3D
152. D Reghellin V Poletti S Tomassett A Dubini A Cavazza G Rossi, et al. 2010 Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitis Sarcoidosis Vasc Diffuse Lung Dis 27 1 57 63 21086906 1:STN:280:DC%2BC3cbnvF2lsQ%3D%3D
153. AO Samokhin JY Gauthier MD Percival D Brömme 2011 Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis Respir Res 12 13 21251246 1:CAS:528:DC%2BC3MXhtlyjurs%3D
154. M Woischnik A Bauer R Aboutaam A Pamir F Stanzel J de Blic, et al. 2008 Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis Eur Respir J 31 6 1197 1204 18216060 1:CAS:528:DC%2BD1cXosVWisro%3D
155. C Serveau-Avesque MF-D Martino V Hervé-Grépinet E Hazouard F Gauthier E Diot, et al. 2006 Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids Biol Cell 98 1 15 22 16354158 1:CAS:528:DC%2BD28XhsFeisrg%3D (Pubitemid 43056290)
156. G Lalmanach C Naudin F Lecaille H Fritz 2010 Kininogens: more than cysteine protease inhibitors and kinin precursors Biochimie 92 11 1568 1579 20346387 1:CAS:528:DC%2BC3cXhtl2isLvO
157. F Lazner M Gowen D Pavasovic I Kola 1999 Osteopetrosis and osteoporosis: two sides of the same coin Hum Mol Genet 8 10 1839 1846 10469835 1:CAS:528:DyaK1MXmslemu7w%3D (Pubitemid 29458660)
158. P Saftig E Hunziker O Wehmeyer S Jones A Boyde W Rommerskirch, et al. 1998 Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice Proc Natl Acad Sci USA 95 23 13453 13458 9811821 1:CAS:528:DyaK1cXnsVGhtL4%3D (Pubitemid 28522993)
159. M Gowen F Lazner R Dodds R Kapadia J Feild M Tavaria, et al. 1999 Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization J Bone Miner Res 14 10 1654 1663 10491212 1:CAS:528:DyaK1MXmsFOis7c%3D (Pubitemid 29455813)
160. H Mano T Yuasa T Kameda K Miyazawa Y Nakamaru M Shiokawa, et al. 1996 Mammalian mature osteoclasts as estrogen target cells Biochem Biophys Res Commun 223 3 637 642 8687448 1:CAS:528:DyaK28XjvFCrur4%3D (Pubitemid 26246125)
161. S Desmarais F Massé MD Percival 2009 Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools Biol Chem 390 9 941 948 19453281 1:CAS:528:DC%2BD1MXhtFWjs7jJ
162. DN Deaton AM Hassell RB McFadyen AB Miller LR Miller LM Shewchuk, et al. 2005 Novel and potent cyclic cyanamide-based cathepsin K inhibitors Bioorg Med Chem Lett 15 7 1815 1819 15780613 1:CAS:528:DC%2BD2MXisVCntL8%3D (Pubitemid 40380739)
163. D Brömme F Lecaille 2009 Cathepsin K inhibitors for osteoporosis and potential off-target effects Expert Opin Investig Drugs 18 5 585 600 19388876
164. TD Rachner S Khosla LC Hofbauer 2011 Osteoporosis: now and the future Lancet 377 1276 1287 21450337 1:CAS:528:DC%2BC3MXksFWit7c%3D
165. B Bouvard E Legrand M Audran D Chappard 2009 Glucocorticoid-induced osteoporosis: a review Clinic Rev Bone Miner Metab 8 1 15 26
166. HA Chapman 2011 Epithelial-mesenchymal interactions in pulmonary fibrosis Annu Rev Physiol 73 413 435 21054168 1:CAS:528:DC%2BC3MXktVKjur0%3D
167. K Koli M Myllärniemi K Vuorinen K Salmenkivi MJ Ryynänen VL Kinnula, et al. 2006 Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis Am J Pathol 169 1 61 71 16816361 1:CAS:528:DC%2BD28XnslSnt7o%3D
168. M Myllärniemi P Lindholm MJ Ryynänen CR Kliment K Salmenkivi J Keski-Oja, et al. 2008 Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis Am J Respir Crit Care Med 177 3 321 329 17975199 (Pubitemid 351198376)
169. LA Murray TL Hackett SM Warner F Shaheen RL Argentieri P Dudas, et al. 2008 BMP-7 does not protect against bleomycin-induced lung or skin fibrosis PLoS ONE 3 12 e4039 19112509
170. V Zuzarte-Luis JA Montero Y Kawakami JC Izpisua-Belmonte JM Hurle 2007 Lysosomal cathepsins in embryonic programmed cell death Dev Biol 301 1 205 217 16987511 1:CAS:528:DC%2BD2sXht1WgtA%3D%3D (Pubitemid 44958390)
171. Y Takeda P He I Tachibana B Zhou K Miyado H Kaneko, et al. 2008 Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice J Biol Chem 283 38 26089 26097 18662991 1:CAS:528: DC%2BD1cXhtFSltLjK
172. KG Saag E Shane S Boonen F Marín DW Donley KA Taylor, et al. 2007 Teriparatide or alendronate in glucocorticoid-induced osteoporosis N Engl J Med 357 20 2028 2039 18003959 1:CAS:528:DC%2BD2sXhtlWis7rP (Pubitemid 350106710)
173. ML Johnson MA Kamel 2007 The Wnt signaling pathway and bone metabolism Curr Opin Rheumatol 19 4 376 382 17551370 1:CAS:528:DC%2BD2sXmtV2qtb4%3D (Pubitemid 46884195)
174. A Aicher O Kollet C Heeschen S Liebner C Urbich C Ihling, et al. 2008 The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche Circ Res 103 8 796 803 18776043 1:CAS:528:DC%2BD1cXhtFOis7zF
175. TH Kim S-H Kim J-Y Seo H Chung HJ Kwak S-K Lee, et al. 2011 Blockade of the Wnt/β-catenin pathway attenuates bleomycin-induced pulmonary fibrosis Tohoku J Exp Med 223 1 45 54 21212602 1:CAS:528:DC%2BC3MXisV2nsb0%3D
176. N Kneidinger AÖ Yildirim J Callegari S Takenaka MM Stein R Dumitrascu, et al. 2011 Activation of the WNT/{beta}-catenin pathway attenuates experimental emphysema Am J Respir Crit Care Med 183 6 723 733 20889911 1:CAS:528:DC%2BC3MXlvVWnurY%3D
177. V Leroy S Thurairatnam 2004 Cathepsin S inhibitors Expert Opin Ther Pat 14 3 301 311 1:CAS:528:DC%2BD2cXhslGiurw%3D (Pubitemid 38380268)
178. JO Link S Zipfel 2006 Advances in cathepsin S inhibitor design Curr Opin Drug Discov Devel 9 4 471 482 16889230 1:CAS:528:DC%2BD28XntVChs7g%3D (Pubitemid 44064944)
179. S Gupta RK Singh S Dastidar A Ray 2008 Cysteine cathepsin S as an immunomodulatory target: present and future trends Expert Opin Ther Targets 12 3 291 299 18269339 1:CAS:528:DC%2BD1cXhslKqur0%3D (Pubitemid 351419423)
180. C López-Otín CM Overall 2002 Protease degradomics: a new challenge for proteomics Nat Rev Mol Cell Biol 3 7 509 519 12094217 (Pubitemid 34733432)
181. SD Mason JA Joyce 2011 Proteolytic networks in cancer Trends Cell Biol 21 4 228 237 21232958 1:CAS:528:DC%2BC3MXkt1Gnt78%3D
182. C López-Otín T Hunter 2010 The regulatory crosstalk between kinases and proteases in cancer Nat Rev Cancer 10 4 278 292 20300104